Sorrento Therapeutics, Inc.Sorrento Therapeutics, Inc.Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪16.54 M‬USD
‪−572.84 M‬USD
‪62.84 M‬USD
‪542.56 M‬
Beta (1Y)
−0.69

About Sorrento Therapeutics, Inc.

CEO
Henry H. Ji
Headquarters
San Diego
Employees (FY)
949
Founded
1989
ISIN
US83587F2020
FIGI
BBG000BDM2G2
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SRNEQ is 0.0300 USD — it has increased by 3.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sorrento Therapeutics, Inc. stocks are traded under the ticker SRNEQ.
Sorrento Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
SRNEQ earnings for the last quarter are −0.54 USD whereas the estimation was −0.25 USD which accounts for −116.00% surprise. Estimated earnings for the next quarter are −0.26 USD. See more details about Sorrento Therapeutics, Inc. earnings.
Sorrento Therapeutics, Inc. revenue for the last quarter amounts to ‪11.46 M‬ USD despite the estimated figure of ‪18.75 M‬ USD. In the next quarter revenue is expected to reach ‪13.60 M‬ USD.
Yes, you can track Sorrento Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, SRNEQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sorrento Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
SRNEQ reached its all-time high on Feb 15, 2007 with the price of 750.0000 USD, and its all-time low was 0.0010 USD and was reached on Jan 30, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 949.00 employees. See our rating of the largest employees — is Sorrento Therapeutics, Inc. on this list?